Velocity Clinical Research
MARCH 23, 2025
Clinical trials have been steadily leaving the UK for years. In 2021, just 2.2% of patients recruited to global trials were from the UK. By contrast, France, which has a similar population size, accounted for 3.9% that year. Thats not to say we dont still have some clout (the UK ranks fourth globally for Phase II trials ), but the trending outflow needs to be addressed.
JAMA Internal Medicine
MARCH 23, 2025
This population-based, cross-sectional study investigates avoidable mortality trends and health care spending in all US states compared with member countries of the European Union and Organisation for Economic Co-operation and Development.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
MARCH 23, 2025
For roughly one in every hundred people, food containing even the smallest amounts of gluten can deliver a gutful of hurt and pose severe risks to their health.
JAMA Internal Medicine
MARCH 23, 2025
This essay discusses improving active shooter trainings for health care professionals to include a focus on prevention, acknowledge the range of gun violence, including suicide, and include support resources for participants.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
FDA Law Blog
MARCH 23, 2025
By Deborah L. Livornese On Friday, March 21, 2025, FDA announced that it was further delaying the effective date for the ACNU final rule until May 27, 2025. We wrote about the December 26, 2024 publication of the final rule (89 FR 105288) here. Originally, the Nonprescription Drug Product with an Additional Condition for Nonprescription Use (ACNU) final rule was to become effective January 27, 2025.
JAMA Internal Medicine
MARCH 23, 2025
This cohort study examines the use of cholinesterase inhibitors and memantine among older adults with dementia after admission into hospice care despite the medications limited clinical benefit following enrollment into hospice.
Expert insights. Personalized for you.
52 
Let's personalize your content